KBC Group NV Has $152,000 Stake in Envista Holdings Co. (NYSE:NVST)

KBC Group NV boosted its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 63.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,903 shares of the company’s stock after acquiring an additional 3,082 shares during the quarter. KBC Group NV’s holdings in Envista were worth $152,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in NVST. Nuance Investments LLC raised its stake in Envista by 4.4% during the 3rd quarter. Nuance Investments LLC now owns 7,346,534 shares of the company’s stock valued at $145,168,000 after purchasing an additional 308,221 shares during the last quarter. Clarkston Capital Partners LLC raised its position in shares of Envista by 0.4% during the third quarter. Clarkston Capital Partners LLC now owns 4,347,300 shares of the company’s stock valued at $85,903,000 after buying an additional 17,085 shares during the last quarter. Franklin Resources Inc. lifted its stake in shares of Envista by 26.5% in the third quarter. Franklin Resources Inc. now owns 3,971,662 shares of the company’s stock valued at $78,480,000 after buying an additional 830,861 shares during the period. Pacer Advisors Inc. grew its position in Envista by 22.2% during the third quarter. Pacer Advisors Inc. now owns 3,529,827 shares of the company’s stock worth $69,749,000 after buying an additional 642,401 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in Envista by 2.5% during the third quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company’s stock valued at $57,233,000 after acquiring an additional 71,435 shares during the period.

Envista Stock Performance

Shares of NVST opened at $21.76 on Friday. The firm has a market cap of $3.75 billion, a P/E ratio of -2.80, a PEG ratio of 1.82 and a beta of 1.34. Envista Holdings Co. has a twelve month low of $15.15 and a twelve month high of $24.79. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.08. The firm’s 50 day moving average price is $19.97 and its two-hundred day moving average price is $19.10.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. On average, analysts forecast that Envista Holdings Co. will post 0.72 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on NVST. Piper Sandler raised their price objective on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Monday. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and lifted their price objective for the company from $16.00 to $23.00 in a report on Thursday, October 31st. Morgan Stanley increased their target price on Envista from $19.00 to $20.00 and gave the stock an “equal weight” rating in a report on Thursday. Leerink Partnrs upgraded Envista from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 31st. Finally, Mizuho started coverage on Envista in a report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $20.21.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.